Laddar...
The Discovery and Development of Liraglutide and Semaglutide
The discovery of glucagon-like peptide-1 (GLP-1), an incretin hormone with important effects on glycemic control and body weight regulation, led to efforts to extend its half-life and make it therapeutically effective in people with type 2 diabetes (T2D). The development of short- and then long-acti...
Sparad:
| I publikationen: | Front Endocrinol (Lausanne) |
|---|---|
| Huvudupphovsmän: | , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
Frontiers Media S.A.
2019
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6474072/ https://ncbi.nlm.nih.gov/pubmed/31031702 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fendo.2019.00155 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|